These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

557 related articles for article (PubMed ID: 26199647)

  • 1. Superior Performance of Aptamer in Tumor Penetration over Antibody: Implication of Aptamer-Based Theranostics in Solid Tumors.
    Xiang D; Zheng C; Zhou SF; Qiao S; Tran PH; Pu C; Li Y; Kong L; Kouzani AZ; Lin J; Liu K; Li L; Shigdar S; Duan W
    Theranostics; 2015; 5(10):1083-97. PubMed ID: 26199647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Precise delivery of celastrol by PEGylated aptamer dendrimer nanoconjugates for enormous therapeutic effect via superior intratumor penetration over antibody counterparts.
    Niu B; Wu Y; Zhou M; Lin R; Ge P; Chen X; Zhou H; Zhang X; Xie J
    Cancer Lett; 2023 Nov; 579():216461. PubMed ID: 37898358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor targeting by an aptamer.
    Hicke BJ; Stephens AW; Gould T; Chang YF; Lynott CK; Heil J; Borkowski S; Hilger CS; Cook G; Warren S; Schmidt PG
    J Nucl Med; 2006 Apr; 47(4):668-78. PubMed ID: 16595502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using Peptide Aptamer Targeted Polymers as a Model Nanomedicine for Investigating Drug Distribution in Cancer Nanotheranostics.
    Zhao Y; Houston ZH; Simpson JD; Chen L; Fletcher NL; Fuchs AV; Blakey I; Thurecht KJ
    Mol Pharm; 2017 Oct; 14(10):3539-3549. PubMed ID: 28880092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selection of DNA aptamers against epithelial cell adhesion molecule for cancer cell imaging and circulating tumor cell capture.
    Song Y; Zhu Z; An Y; Zhang W; Zhang H; Liu D; Yu C; Duan W; Yang CJ
    Anal Chem; 2013 Apr; 85(8):4141-9. PubMed ID: 23480100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aptamers as Versatile Ligands for Biomedical and Pharmaceutical Applications.
    Guan B; Zhang X
    Int J Nanomedicine; 2020; 15():1059-1071. PubMed ID: 32110008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-epithelial cell adhesion molecule RNA aptamer-conjugated liposomal doxorubicin as an efficient targeted therapy in mice bearing colon carcinoma tumor model.
    Mashreghi M; Zamani P; Karimi M; Mehrabian A; Arabsalmani M; Zarqi J; Moosavian SA; Jaafari MR
    Biotechnol Prog; 2021 May; 37(3):e3116. PubMed ID: 33369269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aptamer-targeted oligonucleotide theranostics: a smarter approach for brain delivery and the treatment of neurological diseases.
    Sriramoju B; Kanwar R; Veedu RN; Kanwar JR
    Curr Top Med Chem; 2015; 15(12):1115-24. PubMed ID: 25866271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aptamers and their applications in nanomedicine.
    Sun H; Zu Y
    Small; 2015 May; 11(20):2352-64. PubMed ID: 25677591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A New Theranostic System Based on Endoglin Aptamer Conjugated Fluorescent Silica Nanoparticles.
    Tan J; Yang N; Zhong L; Tan J; Hu Z; Zhao Q; Gong W; Zhang Z; Zheng R; Lai Z; Li Y; Zhou C; Zhang G; Zheng D; Zhang Y; Wu S; Jiang X; Zhong J; Huang Y; Zhou S; Zhao Y
    Theranostics; 2017; 7(19):4862-4876. PubMed ID: 29187909
    [No Abstract]   [Full Text] [Related]  

  • 11. Improvement in the drug delivery and anti-tumor efficacy of PEGylated liposomal doxorubicin by targeting RNA aptamers in mice bearing breast tumor model.
    Moosavian SA; Abnous K; Badiee A; Jaafari MR
    Colloids Surf B Biointerfaces; 2016 Mar; 139():228-36. PubMed ID: 26722819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-EGF Receptor Aptamer-Guided Co-Delivery of Anti-Cancer siRNAs and Quantum Dots for Theranostics of Triple-Negative Breast Cancer.
    Kim MW; Jeong HY; Kang SJ; Jeong IH; Choi MJ; You YM; Im CS; Song IH; Lee TS; Lee JS; Lee A; Park YS
    Theranostics; 2019; 9(3):837-852. PubMed ID: 30809312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An aptamer-antibody complex (oligobody) as a novel delivery platform for targeted cancer therapies.
    Heo K; Min SW; Sung HJ; Kim HG; Kim HJ; Kim YH; Choi BK; Han S; Chung S; Lee ES; Chung J; Kim IH
    J Control Release; 2016 May; 229():1-9. PubMed ID: 26956592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nucleic Acid Aptamers as Emerging Tools for Diagnostics and Theranostics.
    Mutreja R; Baba SA; Navani NK
    Methods Mol Biol; 2019; 2054():201-221. PubMed ID: 31482458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aptamers in targeted nanotherapy.
    Mathew A; Maekawa T; Sakthikumar D
    Curr Top Med Chem; 2015; 15(12):1102-14. PubMed ID: 25866269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epithelial cell adhesion molecule aptamer conjugated PEG-PLGA nanopolymersomes for targeted delivery of doxorubicin to human breast adenocarcinoma cell line in vitro.
    Alibolandi M; Ramezani M; Sadeghi F; Abnous K; Hadizadeh F
    Int J Pharm; 2015 Feb; 479(1):241-51. PubMed ID: 25529433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of affinity and antigen internalization on the uptake and penetration of Anti-HER2 antibodies in solid tumors.
    Rudnick SI; Lou J; Shaller CC; Tang Y; Klein-Szanto AJ; Weiner LM; Marks JD; Adams GP
    Cancer Res; 2011 Mar; 71(6):2250-9. PubMed ID: 21406401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polyfluoroalkyl Tag Decoration Enables Significantly Enhanced Tumor Penetration Ability of a PTK7 Targeting Aptamer.
    Li Y; Zhang C; Fu T; Wang XQ; Tan W
    Bioconjug Chem; 2024 May; 35(5):674-681. PubMed ID: 38695582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EpCAM-Targeting Aptamer Radiotracer for Tumor-Specific PET Imaging.
    Li F; Zeng Z; Hamilton D; Zu Y; Li Z
    Bioconjug Chem; 2021 Jun; 32(6):1139-1145. PubMed ID: 34014641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor targeting with a (99m)Tc-labeled AS1411 aptamer in prostate tumor cells.
    Noaparast Z; Hosseinimehr SJ; Piramoon M; Abedi SM
    J Drug Target; 2015; 23(6):497-505. PubMed ID: 25673264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.